Nitric-Oxide-Releasing Dexamethasone Derivative NCX-1005 Improves Lung Function and Attenuates Inflammation in Experimental Lavage-Induced ARDS
Kosutova, P.; Kolomaznik, M.; Calkovska, A.; Mokra, D.; Mikolka, P. Nitric-Oxide-Releasing Dexamethasone Derivative NCX-1005 Improves Lung Function and Attenuates Inflammation in Experimental Lavage-Induced ARDS. Pharmaceutics 2021, 13, 2092. https://doi.org/10.3390/pharmaceutics13122092
Kosutova P, Kolomaznik M, Calkovska A, Mokra D, Mikolka P. Nitric-Oxide-Releasing Dexamethasone Derivative NCX-1005 Improves Lung Function and Attenuates Inflammation in Experimental Lavage-Induced ARDS. Pharmaceutics. 2021; 13(12):2092. https://doi.org/10.3390/pharmaceutics13122092
Chicago/Turabian StyleKosutova, Petra, Maros Kolomaznik, Andrea Calkovska, Daniela Mokra, and Pavol Mikolka. 2021. "Nitric-Oxide-Releasing Dexamethasone Derivative NCX-1005 Improves Lung Function and Attenuates Inflammation in Experimental Lavage-Induced ARDS" Pharmaceutics 13, no. 12: 2092. https://doi.org/10.3390/pharmaceutics13122092